What one share of Erasca holds
We are a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Molecular alterations in RAS, the most frequently mutated oncogene, and the MAPK pathway, one of the most frequently altered signaling pathways in cancer, account for more than five million new patients diagnosed with cancer globally each year.
Erasca’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$0.97 |
|---|---|
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$0.33 |
| Dividends | $0.00 |
| Cash and investments | $1.23 |
| Book value | $1.16 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2020 | — | −$4.83 | — | — | — | −$5.20 |
| 2021 | — | −$1.85 | $0.17 | −$1.37 | — | $3.83 |
| 2022 | — | −$1.99 | $0.12 | −$0.97 | $0.00 | $2.76 |
| 2023 | — | −$0.83 | $0.01 | −$0.69 | $0.00 | $2.10 |
| 2024 | — | −$0.69 | $0.00 | −$0.47 | $0.00 | $1.50 |
| 2025 | — | −$0.44 | $0.00 | −$0.34 | $0.00 | $1.14 |
Common questions about Erasca
How much does one share of Erasca earn?
Over the last 12 months, Erasca lost $0.97 for each share.
Does Erasca pay a dividend?
Erasca didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Erasca’s book value per share?
Erasca’s book value is $1.16 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Erasca have?
Each share of Erasca has $1.23 of cash and investments, as of June 30, 2026.
What is Erasca’s free cash flow per share?
−$0.33 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Erasca bought back shares?
Erasca’s share count rose about 1248% from 2020 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.